| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10717 | 2021 |
| Treat cancers by targeting survivin: just a dream or future reality? MS Coumar, FY Tsai, JR Kanwar, S Sarvagalla, CHA Cheung Cancer treatment reviews 39 (7), 802-811, 2013 | 187 | 2013 |
| Survivin–biology and potential as a therapeutic target in oncology CHA Cheung, CC Huang, FY Tsai, JYC Lee, SM Cheng, YC Chang, ... OncoTargets and therapy, 1453-1462, 2013 | 187 | 2013 |
| Aurora kinase inhibitors in preclinical and clinical testing CHA Cheung, MS Coumar, HP Hsieh, JY Chang Expert opinion on investigational drugs 18 (4), 379-398, 2009 | 116 | 2009 |
| BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells TY Lin, HH Chan, SH Chen, S Sarvagalla, PS Chen, MS Coumar, ... Autophagy 16 (7), 1296-1313, 2020 | 105 | 2020 |
| YM155 down‐regulates survivin and XIAP, modulates autophagy and induces autophagy‐dependent DNA damage in breast cancer cells SM Cheng, YC Chang, CY Liu, JYC Lee, HH Chan, CW Kuo, KY Lin, ... British journal of pharmacology 172 (1), 214-234, 2015 | 97 | 2015 |
| Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers N Singh, S Krishnakumar, RK Kanwar, CHA Cheung, JR Kanwar Drug discovery today 20 (5), 578-587, 2015 | 94 | 2015 |
| Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers CHA Cheung, HH Chen, CC Kuo, CY Chang, MS Coumar, HP Hsieh, ... Molecular cancer 8, 1-15, 2009 | 92 | 2009 |
| Targeting cathepsin S induces tumor cell autophagy via the EGFR–ERK signaling pathway KL Chen, WSW Chang, CHA Cheung, CC Lin, CC Huang, YN Yang, ... Cancer letters 317 (1), 89-98, 2012 | 87 | 2012 |
| Investigations of survivin: the past, present and future CHA Cheung, LT Cheng, KY Chang, HH Chen, JY Chang Frontiers in Bioscience-Landmark 16 (3), 952-961, 2011 | 75 | 2011 |
| A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy CHA Cheung, X Sun, JR Kanwar, JZ Bai, LT Cheng, GW Krissansen Cancer cell international 10, 1-11, 2010 | 73 | 2010 |
| Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE CHA Cheung, YC Chang, TY Lin, SM Cheng, E Leung Journal of biomedical science 27 (1), 1-10, 2020 | 70 | 2020 |
| Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells CHA Cheung, HH Chen, LT Cheng, KW Lyu, JR Kanwar, JY Chang Molecular cancer 9 (1), 1-11, 2010 | 68 | 2010 |
| Autophagy induced by cathepsin S inhibition induces early ROS production, oxidative DNA damage, and cell death via xanthine oxidase CC Huang, KL Chen, CHA Cheung, JY Chang Free Radical Biology and Medicine 65, 1473-1486, 2013 | 67 | 2013 |
| Inhibition of HDAC3-and HDAC6-promoted survivin expression plays an important role in SAHA-induced autophagy and viability reduction in breast cancer cells JYC Lee, CW Kuo, SL Tsai, SM Cheng, SH Chen, HH Chan, CH Lin, ... Frontiers in pharmacology 7, 81, 2016 | 63 | 2016 |
| Aurora kinase inhibitor patents and agents in clinical testing: an update (2011–2013) CHA Cheung, S Sarvagalla, JYC Lee, YC Huang, MS Coumar Expert opinion on therapeutic patents 24 (9), 1021-1038, 2014 | 61 | 2014 |
| Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer L Ma, H Qiao, C He, Q Yang, CHA Cheung, JR Kanwar, X Sun Investigational new drugs 30, 508-517, 2012 | 60 | 2012 |
| Aurora kinase inhibitor patents and agents in clinical testing: an update (2009–10) This article is an update to aurora kinase inhibitors review, which appeared in: Expert Opin … CHA Cheung, MS Coumar, JY Chang, HP Hsieh Expert opinion on therapeutic patents 21 (6), 857-884, 2011 | 60 | 2011 |
| Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes CHA Cheung, SY Wu, TR Lee, CY Chang, JS Wu, HP Hsieh, JY Chang PloS one 5 (9), e12564, 2010 | 51 | 2010 |
| Mutation of the PTCH1 gene predicts recurrence of breast cancer CY Wang, YC Chang, YL Kuo, KT Lee, PS Chen, CHA Cheung, ... Scientific reports 9 (1), 16359, 2019 | 50 | 2019 |
Mohane Coumar SAssistant Professor, Department of Bioinformatics, Pondicherry UniversityVerified email at bicpu.edu.in
